tetanus-CMV fusion peptide vaccine
Term · Oncology and biomedicine · MLC-T-ONC-017087
A vaccine containing an inactivated epitope of tetanus toxin fused to a cytomegalovirus (CMV) peptide epitope, with potential anti-viral and immunomodulating activities. Upon administration, tetanus-CMV fusion peptide may stimulate a cytotoxic T-lymphocyte (CTL) response against CMV in the CMV-infected host. Tetanus toxin contains universal T cell helper epitopes.
| Identifier | MLC-T-ONC-017087 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017087",
"term": "tetanus-CMV fusion peptide vaccine",
"field": "Oncology and biomedicine",
"definition": "A vaccine containing an inactivated epitope of tetanus toxin fused to a cytomegalovirus (CMV) peptide epitope, with potential anti-viral and immunomodulating activities. Upon administration, tetanus-CMV fusion peptide may stimulate a cytotoxic T-lymphocyte (CTL) response against CMV in the CMV-infected host. Tetanus toxin contains universal T cell helper epitopes.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/tetanus-cmv-fusion-peptide-vaccine/"
}
Record 16,196 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.